As of 2025-06-18, the Fair Value of Candel Therapeutics Inc (CADL) is -3.95 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 5.16 USD, the upside of Candel Therapeutics Inc is -176.55%.
With the market price of 5.16 USD and our fair value calculation, Candel Therapeutics Inc (CADL) is not a good investment. Investing in CADL stocks now will result in a potential loss of 176.55%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -17.68 | -36.12 | -18.79 | -37.94 | -55.18 | -33.14 |
| YoY growth | -114.56% | -104.32% | 47.97% | -101.87% | -45.44% | -63.64% |
| Market Cap (mil) | 258.52 |
| P/E | |
| Forward P/E |
| EPS | -0.79 |
| Avg earnings growth rate | -63.64% |
| TTM earnings | -39.58 |